1Department of Cardiothoracic-Vascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy. 2Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy.
Crit Care Med. 2013 Nov;41(11):2476-83. doi: 10.1097/CCM.0b013e3182978dfc.
Preoperative intra-aortic balloon pump use in high-risk patients undergoing surgical coronary revascularization is still a matter of debate. The objective of this study is to determine whether the preoperative use of an intra-aortic balloon pump improves the outcome after coronary operations in high-risk patients.
Single-center prospective randomized controlled trial.
Tertiary cardiac surgery center, research hospital.
One hundred ten subjects undergoing coronary operations, with a poor left ventricular ejection fraction (< 35%) and no hemodynamic instability.
Patients randomized to receive preincision intra-aortic balloon pump or no intervention.
The primary outcome measurement was postoperative major morbidity rate, defined as one of prolonged mechanical ventilation, stroke, acute kidney injury, surgical revision, mediastinitis, and operative mortality. There was no difference in major morbidity rate (40% in intra-aortic balloon pump group and 31% in control group; odds ratio, 1.49 [95% CI, 0.68-3.33]). No differences were observed for cardiac index before and after the operation; at the arrival in the ICU, patients in the intra-aortic balloon pump group had a significantly (p = 0.01) lower mean systemic arterial pressure (80.1 ± 15.1 mm Hg) versus control group patients (89.2 ± 17.9 mm Hg). Fewer patients in the intra-aortic balloon pump group (24%) than those in the control group (44%) required dopamine infusion (p = 0.043).
This study demonstrates that in patients undergoing nonemergent coronary operations, with a stable hemodynamic profile and a left ventricular ejection fraction less than 35%, the preincision insertion of intra-aortic balloon pump does not result in a better outcome. Given the possible complications of intra-aortic balloon pump insertion, and the additional cost of the procedure, this approach is not justified.
高危患者在接受外科冠状动脉血运重建术前行主动脉内球囊泵治疗仍存在争议。本研究旨在确定高危患者行冠状动脉手术后,术前使用主动脉内球囊泵是否能改善预后。
单中心前瞻性随机对照试验。
三级心脏手术中心,研究医院。
110 例行冠状动脉手术的患者,左心室射血分数(EF)差(<35%)且无血流动力学不稳定。
患者随机接受术前切开主动脉内球囊泵或不干预。
主要终点是术后主要发病率,定义为机械通气延长、中风、急性肾损伤、手术修正、纵隔炎和手术死亡率之一。主要发病率(主动脉内球囊泵组为 40%,对照组为 31%;比值比,1.49[95%CI,0.68-3.33])无差异。手术前后心指数无差异;在 ICU 到达时,主动脉内球囊泵组患者的平均动脉压明显(p=0.01)较低(80.1±15.1mmHg),而对照组患者为(89.2±17.9mmHg)。主动脉内球囊泵组患者(24%)需要多巴胺输注的人数明显少于对照组(44%)(p=0.043)。
本研究表明,在接受非紧急冠状动脉手术、血流动力学稳定且左心室射血分数<35%的患者中,术前切开插入主动脉内球囊泵并不能改善预后。鉴于主动脉内球囊泵插入可能引起的并发症和手术的额外费用,这种方法是不合理的。